Department of Radiology, Rehabilitation and Physiotherapy, Universidad Complutense de Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.
Eur J Pain. 2020 Jul;24(6):1023-1044. doi: 10.1002/ejp.1559. Epub 2020 Apr 4.
To evaluate the effects of percutaneous electrical stimulation (PENS) alone or as an adjunct with other interventions on pain and related disability in musculoskeletal pain conditions.
Search of MEDLINE, EMBASE, AMED, CINAHL, EBSCO, PubMed, PEDro, Cochrane Library, SCOPUS and Web of Science databases. Randomized controlled trials where at least one group received any form of PENS for musculoskeletal condition. Studies had to include humans and collect outcomes on pain and related disability in musculoskeletal pain. Risk of bias was assessed by the Cochrane Guidelines, the quality of evidence by using the GRADE approach. Standardized mean differences (SMD) were calculated.
Sixteen studies were included and included heterogeneous musculoskeletal conditions with short- or midterm follow-ups. PENS alone had a large effect (SMD -1.22, 95% CI -1.66 to -0.79) on pain and a small effect (SMD -0.33, 95% CI -0.61 to -0.06) on related disability at short-term as compared with sham. A moderate effect of PENS alone (SMD -0.71, 95% CI -1.23 to -0.19) on pain when compared with other interventions was observed. The inclusion of PENS with other interventions had a moderate effect for decreasing pain at short- (SMD -0.70, 95% CI -1.02 to -0.37) and midterm (SMD -0.68, 95% CI -1.10 to -0.27). No effect at midterm (SMD -0.21, 95% CI -0.52 to 0.10) on related disability was seen. The risk of bias was generally low; but the heterogenicity of the results downgraded the level of evidence.
There is low level of evidence suggesting the effects of PENS alone or in combination for pain, but not related disability, in musculoskeletal pain.
Therapy, level 1a. Registration number: CRD42019131331.
This meta-analysis investigating the effectiveness of PENS for the management of pain and related disability in musculoskeletal pain conditions found that PENS could decrease level of pain intensity but not relateddisability in musculoskeletal pain disorders.
评估经皮电刺激(PENS)单独使用或与其他干预措施联合使用对肌肉骨骼疼痛疾病的疼痛和相关残疾的影响。
检索 MEDLINE、EMBASE、AMED、CINAHL、EBSCO、PubMed、PEDro、Cochrane 图书馆、SCOPUS 和 Web of Science 数据库。至少有一组接受任何形式的 PENS 治疗肌肉骨骼疾病的随机对照试验。研究必须包括人类,并收集肌肉骨骼疼痛的疼痛和相关残疾的结果。使用 Cochrane 指南评估偏倚风险,使用 GRADE 方法评估证据质量。计算标准化均数差(SMD)。
纳入了 16 项研究,这些研究纳入了具有短期或中期随访的异质肌肉骨骼疾病。与假对照相比,PENS 单独使用在短期(SMD-1.22,95%CI-1.66 至-0.79)对疼痛有较大影响,在短期(SMD-0.33,95%CI-0.61 至-0.06)对相关残疾有较小影响。与其他干预措施相比,PENS 单独使用对疼痛的影响为中度(SMD-0.71,95%CI-1.23 至-0.19)。将 PENS 与其他干预措施联合使用对短期(SMD-0.70,95%CI-1.02 至-0.37)和中期(SMD-0.68,95%CI-1.10 至-0.27)疼痛的减少有中度影响。在中期(SMD-0.21,95%CI-0.52 至 0.10)对相关残疾没有影响。偏倚风险通常较低,但结果的异质性降低了证据水平。
低水平证据表明,PENS 单独或联合使用对肌肉骨骼疼痛的疼痛,但对相关残疾没有影响。
治疗,1a 级。注册号:CRD42019131331。
这项荟萃分析调查了 PENS 治疗肌肉骨骼疼痛疾病疼痛和相关残疾的有效性,发现 PENS 可以降低肌肉骨骼疼痛疾病的疼痛强度,但不能降低相关残疾。